Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 12, 2019JAMA NeurologyOpen Access

Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

View Full Paper
Ask AI
Bookmark
Share

Authors

ECEster CantóUniversitat Autònoma de BarcelonaCBChristian BarroBrigham and Women's HospitalCZChao ZhaoXuzhou Medical College

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cantó et al. (2019) studied this question.

synapsesocial.com/papers/6a6fd4d6a7fbea1e4407dc23https://doi.org/10.1001/jamaneurol.2019.2137
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Blood neurofilament light chain as a biomarker of MS disease activity and treatment response2019 · 587 citations
  2. 2The clinical utility of JC virus antibody index measurements in the context of progressive multifocal leukoencephalopathy2017 · 25 citations
  3. 3Rating neurologic impairment in multiple sclerosis1983 · 15,120 citations
  4. 4Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival2017 · 78 citations
  5. 5Established and novel disease‐modifying treatments in multiple sclerosis2014 · 142 citations